AAAAAA

   
Results: 1-25 | 26-33
Results: 1-25/33
ASAP IS AN EFFECTIVE SALVAGE REGIMEN IN PATIENTS WITH REFRACTORY OR RECURRENT HODGKINS-DISEASE
Authors: RODRIGUEZ J RODRIGUEZ MA FAYAD L HAGEMEISTER B MCLAUGHLIN P SWAN F SARRIS A ROMAGUERA J ANDERSSON B CABANILLAS F
Citation: J. Rodriguez et al., ASAP IS AN EFFECTIVE SALVAGE REGIMEN IN PATIENTS WITH REFRACTORY OR RECURRENT HODGKINS-DISEASE, Blood, 90(10), 1997, pp. 1518-1518
HIGH-RATE OF PROLONGED REMISSIONS FOLLOWING COMBINED-MODALITY THERAPYFOR PATIENTS WITH LOCALIZED LOW-GRADE LYMPHOMA
Authors: SEYMOUR JF MCLAUGHLIN P FULLER LM HAGEMEISTER FB HESS M SWAN F ROMAGUERA J RODRIGUEZ MA BESA P COX J CABANILLAS F
Citation: Jf. Seymour et al., HIGH-RATE OF PROLONGED REMISSIONS FOLLOWING COMBINED-MODALITY THERAPYFOR PATIENTS WITH LOCALIZED LOW-GRADE LYMPHOMA, Annals of oncology, 7(2), 1996, pp. 157-163
FLUDARABINE, MITOXANTRONE, AND DEXAMETHASONE - AN EFFECTIVE NEW REGIMEN FOR INDOLENT LYMPHOMA
Authors: MCLAUGHLIN P HAGEMEISTER FB ROMAGUERA JE SARRIS AH PATE O YOUNES A SWAN F KEATING M CABANILLAS F
Citation: P. Mclaughlin et al., FLUDARABINE, MITOXANTRONE, AND DEXAMETHASONE - AN EFFECTIVE NEW REGIMEN FOR INDOLENT LYMPHOMA, Journal of clinical oncology, 14(4), 1996, pp. 1262-1268
NO EFFECT OF 96-HOUR PACLITAXEL INFUSION IN PATIENTS WITH RELAPSED NON-HODGKINS-LYMPHOMA REFRACTORY TO A 3-HOUR INFUSION SCHEDULE
Authors: YOUNES A AYOUB JP HAGEMEISTER FB MCLAUGHLIN P SARRIS A RODRIGUEZ MA SWAN F ROMAGUERA JE MARTIN J CABANILLAS F
Citation: A. Younes et al., NO EFFECT OF 96-HOUR PACLITAXEL INFUSION IN PATIENTS WITH RELAPSED NON-HODGKINS-LYMPHOMA REFRACTORY TO A 3-HOUR INFUSION SCHEDULE, Journal of clinical oncology, 14(2), 1996, pp. 543-548
CYCLOSPORINE-A DOES NOT REVERSE CLINICAL RESISTANCE TO PACLITAXEL IN PATIENTS WITH RELAPSED NON-HODGKINS-LYMPHOMA
Authors: SARRIS AH YOUNES A MCLAUGHLIN P MOORE D HAGEMEISTER F SWAN F RODRIGUEZ MA ROMAGUERA J NORTH L MANSFIELD P CALLENDAR D MESINA O CABANILLAS F
Citation: Ah. Sarris et al., CYCLOSPORINE-A DOES NOT REVERSE CLINICAL RESISTANCE TO PACLITAXEL IN PATIENTS WITH RELAPSED NON-HODGKINS-LYMPHOMA, Journal of clinical oncology, 14(1), 1996, pp. 233-239
RISK CLASSIFICATION FOR LARGE-CELL LYMPHOMA USING LACTATE-DEHYDROGENASE, BETA-2-MICROGLOBULIN, AND THYMIDINE KINASE
Authors: SUKI S SWAN F TUCKER S FRITSCHE HA REDMAN JR RODRIGUEZ MA MCLAUGHLIN P ROMAGUERA J HAGEMEISTER FB VELASQUEZ WS SARRIS AH YOUNES A CABANILLAS F
Citation: S. Suki et al., RISK CLASSIFICATION FOR LARGE-CELL LYMPHOMA USING LACTATE-DEHYDROGENASE, BETA-2-MICROGLOBULIN, AND THYMIDINE KINASE, Leukemia & lymphoma, 18(1-2), 1995, pp. 87-92
A PHASE-II TRIAL OF MESNA IFOSFAMIDE, MITOXANTRONE AND ETOPOSIDE FOR REFRACTORY LYMPHOMAS
Authors: RODRIGUEZ MA CABANILLAS FC HAGEMEISTER FB MCLAUGHLIN P ROMAGUERA JE SWAN F VELASQUEZ W
Citation: Ma. Rodriguez et al., A PHASE-II TRIAL OF MESNA IFOSFAMIDE, MITOXANTRONE AND ETOPOSIDE FOR REFRACTORY LYMPHOMAS, Annals of oncology, 6(6), 1995, pp. 609-611
RESULTS OF A SALVAGE TREATMENT PROGRAM FOR RELAPSING LYMPHOMA - MINE CONSOLIDATED WITH ESHAP
Authors: RODRIGUEZ MA CABANILLAS FC VELASQUEZ W HAGEMEISTER FB MCLAUGHLIN P SWAN F ROMAGUERA JE
Citation: Ma. Rodriguez et al., RESULTS OF A SALVAGE TREATMENT PROGRAM FOR RELAPSING LYMPHOMA - MINE CONSOLIDATED WITH ESHAP, Journal of clinical oncology, 13(7), 1995, pp. 1734-1741
3-HOUR PACLITAXEL INFUSION IN PATIENTS WITH REFRACTORY AND RELAPSED NON-HODGKINS-LYMPHOMA
Authors: YOUNES A SARRIS A MELNYK A ROMAGUERA J MCLAUGHLIN P SWAN F RODRIGUEZ MA HAGEMEISTER F MOORE D NORTH L SMITH TL CABANILLAS F
Citation: A. Younes et al., 3-HOUR PACLITAXEL INFUSION IN PATIENTS WITH REFRACTORY AND RELAPSED NON-HODGKINS-LYMPHOMA, Journal of clinical oncology, 13(3), 1995, pp. 583-587
SIGNIFICANCE OF TUMOR SIZE AND RADIATION-DOSE TO LOCAL-CONTROL IN STAGE I-III DIFFUSE LARGE-CELL LYMPHOMA TREATED WITH CHOP-BLEO AND RADIATION
Authors: FULLER LM KRASIN MJ VELASQUEZ WS ALLEN PK MCLAUGHLIN P RODRIGUEZ MA HAGEMEISTER FB SWAN F CABANILLAS F PALMER JL COX JD
Citation: Lm. Fuller et al., SIGNIFICANCE OF TUMOR SIZE AND RADIATION-DOSE TO LOCAL-CONTROL IN STAGE I-III DIFFUSE LARGE-CELL LYMPHOMA TREATED WITH CHOP-BLEO AND RADIATION, International journal of radiation oncology, biology, physics, 31(1), 1995, pp. 3-11
NO EFFECT OF 96-HOUR PACLITAXEL INFUSION IN PATIENTS WITH RELAPSED NON-HODGKINS-LYMPHOMA (NHL) REFRACTORY TO A 3-HOUR INFUSION SCHEDULE
Authors: YOUNES A AYOUB JP HAGEMEISTER F MCLAUGHLIN P SARRIS A RODRIGUEZ MA SWAN F ROMAGUERA J MARTIN J CABANILLAS F
Citation: A. Younes et al., NO EFFECT OF 96-HOUR PACLITAXEL INFUSION IN PATIENTS WITH RELAPSED NON-HODGKINS-LYMPHOMA (NHL) REFRACTORY TO A 3-HOUR INFUSION SCHEDULE, Blood, 86(10), 1995, pp. 3293-3293
RELATIONSHIP BETWEEN DNA-PLOIDY LEVEL, NUCLEAR SIZE, AND SURVIVAL IN LARGE-CELL LYMPHOMA
Authors: SALMON I SWAN F DARGENT JL PASTEELS JL KISS R KATZ RL
Citation: I. Salmon et al., RELATIONSHIP BETWEEN DNA-PLOIDY LEVEL, NUCLEAR SIZE, AND SURVIVAL IN LARGE-CELL LYMPHOMA, American journal of clinical pathology, 103(5), 1995, pp. 568-573
PRIMARY MEDIASTINAL LARGE-CELL LYMPHOMA IS CHARACTERIZED BY AN INVERTED PATTERN OF LARGE TUMORAL MASS AND LOW BETA(2) MICROGLOBULIN LEVELS IN SERUM AND FREQUENTLY ELEVATED LEVELS OF SERUM LACTATE-DEHYDROGENASE
Authors: RODRIGUEZ J PUGH WC ROMAGUERA JE LUTHRA R HAGEMEISTER FB MCLAUGHLIN P RODRIGUEZ MA SWAN F CABANILLAS F
Citation: J. Rodriguez et al., PRIMARY MEDIASTINAL LARGE-CELL LYMPHOMA IS CHARACTERIZED BY AN INVERTED PATTERN OF LARGE TUMORAL MASS AND LOW BETA(2) MICROGLOBULIN LEVELS IN SERUM AND FREQUENTLY ELEVATED LEVELS OF SERUM LACTATE-DEHYDROGENASE, Annals of oncology, 5(9), 1994, pp. 847-849
GROWTH-INHIBITION OF FOLLICULAR SMALL-CLEAVED-CELL LYMPHOMA-CELLS IN SHORT-TERM CULTURE BY INTERLEUKIN-3
Authors: YOUNES A DRACH J KATZ R JENDIROBA D SABOURIAN MH SARRIS AH SWAN F HILL D CABANILLAS F FORD R ANDREEFF M
Citation: A. Younes et al., GROWTH-INHIBITION OF FOLLICULAR SMALL-CLEAVED-CELL LYMPHOMA-CELLS IN SHORT-TERM CULTURE BY INTERLEUKIN-3, Annals of oncology, 5(3), 1994, pp. 265-268
STAGE, SERUM LDH, AND PERFORMANCE STATUS PREDICT DISEASE PROGRESSION AND SURVIVAL IN HIV-ASSOCIATED LYMPHOMAS
Authors: HAGEMEISTER FB KHETAN R ALLEN P MCLAUGHLIN P RODRIGUEZ MA SWAN F ROMAGUERA JE CABANILLAS F
Citation: Fb. Hagemeister et al., STAGE, SERUM LDH, AND PERFORMANCE STATUS PREDICT DISEASE PROGRESSION AND SURVIVAL IN HIV-ASSOCIATED LYMPHOMAS, Annals of oncology, 5, 1994, pp. 190000041-190000046
THE GALLIUM SCAN PREDICTS RELAPSE IN PATIENTS WITH HODGKINS-DISEASE TREATED WITH COMBINED-MODALITY THERAPY
Authors: HAGEMEISTER FB PURUGGANAN R PODOLOFF DA HESS M RODRIGUEZ MA MCLAUGHLIN P SWAN F ROMAGUERA JE CABANILLAS F
Citation: Fb. Hagemeister et al., THE GALLIUM SCAN PREDICTS RELAPSE IN PATIENTS WITH HODGKINS-DISEASE TREATED WITH COMBINED-MODALITY THERAPY, Annals of oncology, 5, 1994, pp. 190000059-190000063
INTENSIVE CONVENTIONAL-DOSE CHEMOTHERAPY FOR STAGE-IV LOW-GRADE LYMPHOMA - HIGH REMISSION RATES AND REVERSION TO NEGATIVE OF PERIPHERAL-BLOOD BCL-2 REARRANGEMENT
Authors: MCLAUGHLIN P HAGEMEISTER FB SWAN F CABANILLAS F ROMAGUERA J RODRIGUEZ MA LEE MS PATE O SARRIS A YOUNES A
Citation: P. Mclaughlin et al., INTENSIVE CONVENTIONAL-DOSE CHEMOTHERAPY FOR STAGE-IV LOW-GRADE LYMPHOMA - HIGH REMISSION RATES AND REVERSION TO NEGATIVE OF PERIPHERAL-BLOOD BCL-2 REARRANGEMENT, Annals of oncology, 5, 1994, pp. 190000073-190000077
HODGKINS-DISEASE WITH A MEDIASTINAL MASS GREATER-THAN 10 CM - RESULTSOF 4 DIFFERENT TREATMENT APPROACHES
Authors: PRETI A HAGEMEISTER FB MCLAUGHLIN P SWAN F RODRIGUEZ A BESA P COX JD ALLEN PK CABANILLAS F
Citation: A. Preti et al., HODGKINS-DISEASE WITH A MEDIASTINAL MASS GREATER-THAN 10 CM - RESULTSOF 4 DIFFERENT TREATMENT APPROACHES, Annals of oncology, 5, 1994, pp. 190000097-190000100
ESHAP - AN EFFECTIVE CHEMOTHERAPY REGIMEN IN REFRACTORY AND RELAPSINGLYMPHOMA - A 4-YEAR FOLLOW-UP-STUDY
Authors: VELASQUEZ WS MCLAUGHLIN P TUCKER S HAGEMEISTER FB SWAN F RODRIGUEZ MA ROMAGUERA J RUBENSTEIN E CABANILLAS F
Citation: Ws. Velasquez et al., ESHAP - AN EFFECTIVE CHEMOTHERAPY REGIMEN IN REFRACTORY AND RELAPSINGLYMPHOMA - A 4-YEAR FOLLOW-UP-STUDY, Journal of clinical oncology, 12(6), 1994, pp. 1169-1176
PHASE-I STUDY OF THE COMBINATION OF FLUDARABINE, MITOXANTRONE, AND DEXAMETHASONE IN LOW-GRADE LYMPHOMA
Authors: MCLAUGHLIN P HAGEMEISTER FB SWAN F CABANILLAS F PATE O ROMAGUERA JE RODRIGUEZ MA REDMAN JR KEATING M
Citation: P. Mclaughlin et al., PHASE-I STUDY OF THE COMBINATION OF FLUDARABINE, MITOXANTRONE, AND DEXAMETHASONE IN LOW-GRADE LYMPHOMA, Journal of clinical oncology, 12(3), 1994, pp. 575-579
A PHASE-II TRIAL OF ORAL ETOPOSIDE WITH MITOXANTRONE AND IFOSFAMIDE MESNA CONSOLIDATED WITH INTRAVENOUS ETOPOSIDE, METHYLPREDNISOLONE, HIGH-DOSE ARABINOSIDE, AND CISPLATIN AS SALVAGE THERAPY FOR RELAPSING AND OR REFRACTORY LYMPHOMAS/
Authors: ROMAGUERA JE RODRIGUEZ MA HAGEMEISTER FB MCLAUGHLIN P SWAN F MOORE DF SARRIS AH YOUNES A HILL D CABANILLAS F
Citation: Je. Romaguera et al., A PHASE-II TRIAL OF ORAL ETOPOSIDE WITH MITOXANTRONE AND IFOSFAMIDE MESNA CONSOLIDATED WITH INTRAVENOUS ETOPOSIDE, METHYLPREDNISOLONE, HIGH-DOSE ARABINOSIDE, AND CISPLATIN AS SALVAGE THERAPY FOR RELAPSING AND OR REFRACTORY LYMPHOMAS/, Investigational new drugs, 12(3), 1994, pp. 217-222
TREATMENT OF EARLY STAGES OF HODGKINS-DISEASE WITH NOVANTRONE, VINCRISTINE, VINBLASTINE, PREDNISONE, AND RADIOTHERAPY
Authors: HAGEMEISTER FB PURUGGANAN R FULLER L MCLAUGHLIN P SWAN F ROMAGUERA J RODRIGUEZ M CABANILLAS F
Citation: Fb. Hagemeister et al., TREATMENT OF EARLY STAGES OF HODGKINS-DISEASE WITH NOVANTRONE, VINCRISTINE, VINBLASTINE, PREDNISONE, AND RADIOTHERAPY, Seminars in hematology, 31(2), 1994, pp. 36-43
INTERMEDIATE-GRADE LYMPHOMAS TREATED WITH AMIDE-DOXORUBICIN-VINCRISTINE-PREDNISONE-BLEOMYCIN ALTERNATED WITH LOPHOSPHAMIDE-METHOTREXATE-ETOPOSIDE-DEXAMETHASONE - APPLICATION OF PROGNOSTIC MODELS TO DATA-ANALYSIS
Authors: VELASQUEZ WS MCLAUGHLIN P FULLER LM ALLEN PK TUCKER SL SWAN F RODRIGUEZ MA HAGEMEISTER FB CABANILLAS FF
Citation: Ws. Velasquez et al., INTERMEDIATE-GRADE LYMPHOMAS TREATED WITH AMIDE-DOXORUBICIN-VINCRISTINE-PREDNISONE-BLEOMYCIN ALTERNATED WITH LOPHOSPHAMIDE-METHOTREXATE-ETOPOSIDE-DEXAMETHASONE - APPLICATION OF PROGNOSTIC MODELS TO DATA-ANALYSIS, Cancer, 73(9), 1994, pp. 2408-2416
CYCLOSPORINE-A DOES NOT REVERSE CLINICAL RESISTANCE TO PACLITAXEL (TAXOL) IN PATIENTS WITH RELAPSED NON-HODGKINS-LYMPHOMA
Authors: SARRIS AH YOUNES A MCLAUGHLIN P MOORE D HAGEMEISTER F SWAN F RODRIGUEZ MA ROMAGUERA J NORTH L CABANILLAS F
Citation: Ah. Sarris et al., CYCLOSPORINE-A DOES NOT REVERSE CLINICAL RESISTANCE TO PACLITAXEL (TAXOL) IN PATIENTS WITH RELAPSED NON-HODGKINS-LYMPHOMA, Blood, 84(10), 1994, pp. 10000167-10000167
PHASE-II STUDY OF 5-FLUOROURACIL BY PROTRACTED INFUSION IN PATIENTS WITH RELAPSING OR REFRACTORY LYMPHOMA
Authors: ROMAGUERA JE SARRIS AH SWAN F YOUNES A MCLAUGHLIN P RODRIGUEZ MA MOORE DF CABANILLAS F
Citation: Je. Romaguera et al., PHASE-II STUDY OF 5-FLUOROURACIL BY PROTRACTED INFUSION IN PATIENTS WITH RELAPSING OR REFRACTORY LYMPHOMA, Blood, 84(10), 1994, pp. 10000647-10000647
Risultati: 1-25 | 26-33